Webinar Recap | Applications of Electronic Document Management (eTMF) – Breaking with the Old to Build Anew

Source: EClinCloud. Author: EClinCloud.

On June 17, 2022, the webinar "Success and Failure in Clinical Trials: Effective TMF Management for Facing Clinical Trial Inspections and Audits with Confidence," co-hosted by EClinCloud (Shenzhen) Technology Co., Ltd. (hereinafter "EClinCloud") and Tongxieyi, successfully concluded, attracting nearly 10,000 viewers.
The webinar featured three industry experts—Zeng Xiaoxia, Vice President of Product at EClinCloud; Yin Yuanyuan, Deputy General Manager and Medical Department Director at Kangzhe Biotechnology Co., Ltd.; and Han Juan, Co-founder of Shanghai Daoyi Pharmaceutical Technology Co., Ltd.—who shared their respective perspectives on current pain points and challenges in clinical trial TMF management, key points in domestic and international inspections, and how to build a digital TMF management system.
Click to view the webinar replay
Yin Yuanyuan, Deputy General Manager and Medical Department Director at Kangzhe Biotechnology Co., Ltd., noted that only with a sound quality management system can a project achieve reliable quality assurance across different stages. Although most companies' Trial Master File (TMF) indexes have evolved from the basic DIA index, significant differences still remain—much like the saying, "one mother bears nine children, and each is different." Particularly for sponsors that outsource different studies to different CROs, because each CRO uses a different document index, this creates oversight difficulties for the sponsor, reduces management efficiency, and may ultimately affect whether a product passes audits and inspections, or even its market approval.

Zeng Xiaoxia, Vice President of Product at EClinCloud, explained that regulatory authorities in every country review clinical trials of new drugs based on their respective national laws and regulations and internationally accepted clinical trial management practices, and require sponsors of new drugs to provide complete documentation demonstrating whether the clinical trial protected the rights and interests of subjects and generated scientific data. The TMF contains the primary essential documents of a clinical trial, collected by the sponsor and the investigator throughout the entire course of the trial; it must be able to reconstruct the clinical trial project to ensure the integrity of the trial, and it also serves as a critical component of the "evidence." Therefore, without TMF records as proof, there is no evidence to substantiate the clinical trial procedures. When regulatory authorities conduct audits and inspections, they also typically begin with the TMF documents, so managing TMF documentation effectively has a direct bearing on the success or failure of a clinical trial.

Han Juan, Co-founder of Shanghai Daoyi Pharmaceutical Technology Co., Ltd., stated that relatively common findings in TMF audits and inspections include: failure to establish a TMF management process or a study-specific TMF management plan; incomplete TMF filing, misfiling, duplicate filing, or an unclear document structure and index (such as confusing indexing); and a lack of effective end-to-end quality control (QC) over the TMF, among others. Han Juan noted that the TMF is in fact a record of the entire clinical trial process, and by reviewing the records in the TMF, the observations and conclusions of the trial can be reconstructed. Likewise, documented records serve as evidence of data authenticity and integrity, and teams must remember to maintain Inspection Readiness at all times.

As clinical trials are conducted globally, organizing the TMF has become increasingly complex. To do good work, one must first have the right tools. Benefiting from the steady advancement of digital technology, an electronic TMF—eTMF—is a better choice. As paper submissions transition toward electronic regulatory submissions, electronic Trial Master File (eTMF) management systems have also become the most widely used clinical research information systems after EDC and CTMS.
EClinCloud's Technical Solution for TMF Management
Establishing a secure data management system to keep clinical research activities organized and compliant with regulatory requirements further helps pharmaceutical companies gain market access.
EClinCloud's eTMF is a system that helps pharmaceutical companies and sponsors manage their TMF effectively.

Click the image below
View EClinCloud eTMF product details
☟ ☟ ☟
About EClinCloud
EClinCloud is a healthcare and life sciences technology company based in China and serving clients worldwide. Guided by the mission of "bringing effective treatments to patients through technological innovation" and driven by science and medicine, it combines digital technology with life sciences data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.




